New drug could be a breakthrough in treatment for killer TB, trial suggests

The Guardian – ScienceWednesday, November 19, 2025 at 10:00:12 AM
PositiveScience
New drug could be a breakthrough in treatment for killer TB, trial suggests
  • Sorfequiline has demonstrated stronger efficacy than current TB treatments, indicating a significant advancement in the fight against this deadly disease. This breakthrough could lead to improved patient outcomes and a reduction in TB
  • The implications of this development are profound, as it may enhance global health efforts to combat tuberculosis, which remains a major public health challenge, particularly in high
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Electroconvulsive therapy may have more adverse effects than thought
NegativeScience
A recent study suggests that electroconvulsive therapy (ECT) may lead to a broader range of adverse effects than previously recognized, prompting calls for a suspension of its use until further research is conducted. While memory loss is a known consequence of ECT, researchers identified 25 additional concerning side effects, including cardiovascular issues, fatigue, and emotional blunting.
Pinprick blood test could detect disease 10 years before symptoms appear, study finds
PositiveScience
A new study indicates that pinprick blood tests could identify diseases such as diabetes, cancer, and dementia up to ten years before symptoms manifest. This research, stemming from the UK Biobank's analysis of nearly 250 different blood components from half a million volunteers, aims to create a range of tests that provide detailed physiological insights.